FDA Inspection 779822 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3000151819

The FDA completed an inspection of Novo Nordisk A/S on Mar 20, 2012 in Bagsvard. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Mar 20, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bagsvard (Denmark)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.